Zimmer Biomet Holdings Inc (ZBH):企業の財務・戦略的SWOT分析

◆英語タイトル:Zimmer Biomet Holdings Inc (ZBH) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1301
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Zimmer Biomet Holdings Inc (ZBH) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Zimmer Biomet Holdings Inc (Zimmer Biomet) is a medical device company that focuses on musculoskeletal healthcare. The company designs, manufactures, and markets orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, craniomaxillofacial and thoracic products; office based technologies; dental implants; and related surgical products. Its products and solutions assist in treating patients suffering from disorders or injuries in bones, joints and supporting soft tissues. Zimmer Biomet offers products to orthopaedic surgeons, oral surgeons, neurosurgeons, other specialists, dentists, stocking distributors, hospitals, healthcare dealers and healthcare purchasing organizations. The company markets products through direct sales channels and distributors in Americas, Europe, Asia-Pacific, the Middle East and Africa. Zimmer Biomet is headquartered in Warsaw, Indiana, the US.

Zimmer Biomet Holdings Inc Key Recent Developments

Mar 10,2020: Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2020
Feb 28,2020: Zimmer Biomet Holdings to Present at Raymond James & Associates’ 41st Annual Institutional Investors Conference
Feb 04,2020: Zimmer Biomet announces fourth quarter and full-year 2019 financial results
Jan 08,2020: Zimmer Biomet appoints Keri P. Mattox as Senior Vice President of Investor Relations and Chief Communications Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Zimmer Biomet Holdings Inc – Key Facts
Zimmer Biomet Holdings Inc – Key Employees
Zimmer Biomet Holdings Inc – Key Employee Biographies
Zimmer Biomet Holdings Inc – Major Products and Services
Zimmer Biomet Holdings Inc – History
Zimmer Biomet Holdings Inc – Company Statement
Zimmer Biomet Holdings Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Zimmer Biomet Holdings Inc – Business Description
Product Category: Dental
Overview
Performance
Product Category: Hips
Overview
Performance
Product Category: Knees
Overview
Performance
Product Category: Other
Overview
Performance
Product Category: S.E.T
Overview
Performance
Product Category: Spine & CMF
Overview
Performance
Geographical Segment: Americas
Target Markets
Performance
Geographical Segment: Asia Pacific
Target Markets
Performance
Geographical Segment: EMEA
Target Markets
Performance
R&D Overview
Zimmer Biomet Holdings Inc – Corporate Strategy
Zimmer Biomet Holdings Inc – SWOT Analysis
SWOT Analysis – Overview
Zimmer Biomet Holdings Inc – Strengths
Zimmer Biomet Holdings Inc – Weaknesses
Zimmer Biomet Holdings Inc – Opportunities
Zimmer Biomet Holdings Inc – Threats
Zimmer Biomet Holdings Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Zimmer Biomet Holdings Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Zimmer Biomet Holdings Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Zimmer Biomet Holdings Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 04, 2020: Zimmer Biomet announces fourth quarter and full-year 2019 financial results
Jan 08, 2020: Zimmer Biomet appoints Keri P. Mattox as Senior Vice President of Investor Relations and Chief Communications Officer
Nov 05, 2019: Zimmer Biomet announces third quarter 2019 financial results
Jul 26, 2019: Zimmer Biomet announces second quarter 2019 financial results
Jun 19, 2019: Zimmer Biomet announces chief financial officer transition plan
Apr 26, 2019: Zimmer Biomet announces first quarter 2019 financial results
Feb 01, 2019: Zimmer Biomet announces fourth quarter and full-year 2018 financial results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Zimmer Biomet Holdings Inc, Key Facts
Zimmer Biomet Holdings Inc, Key Employees
Zimmer Biomet Holdings Inc, Key Employee Biographies
Zimmer Biomet Holdings Inc, Major Products and Services
Zimmer Biomet Holdings Inc, History
Zimmer Biomet Holdings Inc, Subsidiaries
Zimmer Biomet Holdings Inc, Key Competitors
Zimmer Biomet Holdings Inc, Ratios based on current share price
Zimmer Biomet Holdings Inc, Annual Ratios
Zimmer Biomet Holdings Inc, Annual Ratios (Cont...1)
Zimmer Biomet Holdings Inc, Annual Ratios (Cont...2)
Zimmer Biomet Holdings Inc, Interim Ratios
Zimmer Biomet Holdings Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Zimmer Biomet Holdings Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Zimmer Biomet Holdings Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Zimmer Biomet Holdings Inc, Performance Chart (2015 - 2019)
Zimmer Biomet Holdings Inc, Ratio Charts
Zimmer Biomet Holdings Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Zimmer Biomet Holdings Inc, Medical Equipment, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Zimmer Biomet Holdings Inc (ZBH):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Elephant Oil Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Elephant Oil Ltd (Elephant Oil) is an oil and gas company. The company provides services such as exploration and production of oil and natural gas. It provides its exploration services in the underexplored areas of West Africa. Elephant Oil holds interest in a production-sharing contract in …
  • FMC Corporation:企業の戦略・SWOT・財務情報
    FMC Corporation - Strategy, SWOT and Corporate Finance Report Summary FMC Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Mediware Information Systems Inc-製薬・医療分野:企業M&A・提携分析
    Summary Mediware Information Systems Inc (Mediware) is a healthcare solutions company that designs, develops and commercializes specialized healthcare software. It provides software to healthcare and human service providers and payers. The company’s portfolio of solutions are equipped in blood banks …
  • Chevron Corporation:企業の戦略・SWOT・財務情報
    Chevron Corporation - Strategy, SWOT and Corporate Finance Report Summary Chevron Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Pronto Diagnostics Ltd-医療機器分野:企業M&A・提携分析
    Summary Pronto Diagnostics Ltd (PDL) is a medical device company that offers molecular diagnostic products and services. The company develops, produces and distributes SNP-detection kits providing assays for detecting polymorphisms in DNA sequences with genetic diseases and predisposition to disease …
  • 2-BBB Medicines BV:製薬・医療:M&Aディール及び事業提携情報
    Summary 2-BBB Medicines BV (2-BBB), formerly to-BBB Therapeutics BV is a biotechnology company that develops medicines for the treatment of brain cancer and neuro-inflammatory diseases. The company develops medicines using its proprietary liposomal drug delivery platform, G-Technology. Its pipeline …
  • Alkermes Plc (ALKS):企業の財務・戦略的SWOT分析
    Alkermes Plc (ALKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Synaffix BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Synaffix BV (Synaffix) is a biotechnology company that discovers and develops site-specific antibody-drug conjugates technology platforms. The company develops its products through its proprietary technology and GlycoConnect. It constructs homogenous and stable ADCs with the aid of a payload …
  • Town Health International Medical Group Ltd (3886):企業の財務・戦略的SWOT分析
    Summary Town Health International Medical Group Ltd (THIMGL), formerly Town Health International Investments Ltd, a subsidiary of Hong Kong Health Check and Medical Diagnostic Group Ltd, is a healthcare service provider. The organization offers medical platform, chain clinics, specialty centres, man …
  • Albany Molecular Research Inc-製薬・医療分野:企業M&A・提携分析
    Summary Albany Molecular Research Inc (AMRI) is a contract research and manufacturing organization. Its service portfolio drug discovery and development, manufacturing of Active Pharmaceutical Ingredients (API); process scale up development of fine chemicals and aseptic filling services for preclini …
  • Delaware Municipal Electric Corporation, Inc.:企業の戦略的SWOT分析
    Delaware Municipal Electric Corporation, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Total E&P USA Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Total E&P USA Inc (TEP USA) formerly Elf Exploration Inc, a subsidiary of Total S.A., is an energy service providing company that explores and produces crude oil and natural gas. The company offers offshore oil production and exploration in the Gulf of Mexico to onshore unconventional shale …
  • Chiyoda Corp (6366):企業の財務・戦略的SWOT分析
    Chiyoda Corp (6366) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Turboatom (TATM):企業の財務・戦略的SWOT分析
    Turboatom (TATM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Smrt Corporation Ltd.:企業の戦略・SWOT・財務分析
    Smrt Corporation Ltd. - Strategy, SWOT and Corporate Finance Report Summary Smrt Corporation Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Glacier Media Inc. (GVC):企業の財務・戦略的SWOT分析
    Glacier Media Inc. (GVC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Themis Bioscience GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Themis Bioscience GmbH (Themis Bioscience) is a biotechnology company that develops prophylactic vaccines for emerging tropical infections. The company develops emerging and specialist indications and vaccines from preclinical to late-stage clinical development phases. It develops novel vacc …
  • Trinity Health:企業の戦略・SWOT・財務分析
    Trinity Health - Strategy, SWOT and Corporate Finance Report Summary Trinity Health - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Dominium S.A.:企業の戦略・SWOT・財務情報
    Dominium S.A. - Strategy, SWOT and Corporate Finance Report Summary Dominium S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Aker ASA (AKER)-石油・ガス分野:企業M&A・提携分析
    Summary Aker ASA (Aker) is an industrial investment company, which operates through in two areas, Industrial Holdings and Financial Investments. It invests mainly in energy, environment, fisheries and marine biotech, and finance. Its Industrial Holdings include Aker Solutions ASA, Aker BP, Akastor A …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆